Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator TherapyTomohisa Nezu, Ḱazunori Toyoda, Satoshi Okuda et al.|Stroke|2011Cited by 122
Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PATomohisa Nezu, Ḱazunori Toyoda, Masatoshi Koga et al.|Neurology|2010Cited by 106
Intravenous Recombinant Tissue Plasminogen Activator Therapy for Stroke Patients Receiving Maintenance Hemodialysis: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA RegistryMasaki Naganuma, Mayumi Mori, Tomohisa Nezu et al.|European Neurology|2011Cited by 15
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA RegistryMasatoshi Koga, Ḱazunori Toyoda, Kazumi Kimura et al.|Journal of the Neurological Sciences|2011Cited by 14
Central apnoea associated with subcortical haemorrhage in the left temporal lobeTomohisa Nezu, Kazuo Minematsu, Masaki Naganuma et al.|Journal of Neurology Neurosurgery & Psychiatry|2010Cited by 1